During the past decade, Providence Health Care conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Health Care" #1 sponsor was "University of British Columbia" with 3 trials, followed by "NCIC Clinical Trials Group" with 2 trials sponsored, "Bioventus LLC" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Health Care" #1 collaborator was "Providence Healthcare" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Brain Canada" with 1 trials as a collaborator and "Canadian Frailty Network" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Providence Health Care" are "Alzheimer Disease" (1 trials), "Atherosclerosis" (1 trials), "Bladder Cancer" (1 trials), "Breast Cancer" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Providence Health Care" in a lesser frequency.

Most popular intervention types in "Providence Health Care" are "Drug" (5 trials), "Device" (4 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alzheimer's disease CSF biomarkers" (1 trials), "COVID-19 barrier box" (1 trials), "Durolane SJ" (1 trials), "Laparoscopic sacral hysteropexy" (1 trials) and "Nasal bridle securement device for small bore feeding tubes" (1 trials). Other intervention names were less common.

The vast majority of trials in "Providence Health Care" are 11 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Providence Health Care". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Providence Health Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Providence Health Care, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".